FDA Drug recall D-0424-2015
B-Lipo, 30 Capsules, Manufactured by KM DALI, Kunming, China for Bethel Nutritional Consulting, Inc.599 West 190th Street, Suite #1 NYC, NY…
- FDA Drug
- Class II
- terminated
- Published 2015-04-01
On 2015-04-01 the FDA classified a Class II recall of B-Lipo, 30 Capsules, Manufactured by KM DALI, Kunming, China for Bethel Nutritional Consulting, Inc.599 West 190th Street, Suite #1 NYC, NY… by Bethel Nutritional Consulting, citing marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0424-2015 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-12-19 |
| Published | 2015-04-01 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Bethel Nutritional Consulting |
| Distribution | US |
Product
B-Lipo, 30 Capsules, Manufactured by KM DALI, Kunming, China for Bethel Nutritional Consulting, Inc.599 West 190th Street, Suite #1 NYC, NY 10040.
Reason
Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss
Identifiers
| code_info | Lot #: 20213, Exp 12/22/2016. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0424-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.